Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • Reporting Rate Calculator
  • Signal Detection
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Myocarditis
  • Guillain-Barré
  • Allergic Reactions
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenImmigration
  • OpenSubsidies
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. COVID-19 Vaccine
  4. Trigeminal neuralgia
COVID-19 Vaccine×Trigeminal neuralgia

Trigeminal neuralgia Reports for COVID-19 Vaccine

#997 most reported symptom for this vaccine

374
Reports
1
Deaths
43
Hospitalizations
0.27
Mortality Rate
%
11.5
Hosp. Rate
%

Trigeminal neuralgia and COVID-19 Vaccine

Trigeminal neuralgia has been reported 374 times in association with COVID-19 Vaccine vaccination in VAERS. This represents 0.0% of all 1,121,388 reports for this vaccine.

Among these reports, 1 mentioned death (0.27%) and 43 involved hospitalization (11.5%).

Trigeminal neuralgia is the #997 most frequently reported symptom for COVID-19 Vaccine out of 9223 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 374 reports of Trigeminal neuralgia after COVID-19 Vaccine vaccination may seem alarming, but context is critical. With 1,121,388 total reports for this vaccine (representing many millions of doses), Trigeminal neuralgia appears in only 0.0% of reports.

The mortality rate among these reports is very low at 0.27%, suggesting most cases are non-fatal.

Important Context

•Association, not causation: These reports show Trigeminal neuralgia occurred after vaccination, not that the vaccine caused it.
•Background rates: Trigeminal neuralgia may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Spinal X-ray375 reportsEmphysema375 reportsViral test negative373 reportsAutonomic nervous system imbalance372 reports

Quick Facts

Reports:374
Deaths:1
Hospitalizations:43
% of Vaccine:0.0%
Rank:#997 of 9223

Related Pages

COVID-19 Vaccine OverviewTrigeminal neuralgia (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.